Price movement over the last 24 hours
ARK Genomic Revolution ETF vs EOG Resources Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while EOG Resources Inc trades at $136.24 (market cap $71.43B). The key difference: EOG Resources Inc pays a 3.04% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, EOG Resources Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | EOG | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $149.89 |
52-Week Low | $23.09 | $101.78 |
Market Cap | — | $71.43B |
Enterprise Value | — | $75.88B |
Dividend Yield | — | 3.04% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EOG Resources trades at $134.10, up 0.42% with a bullish technical outlook and strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $3.41 exceeding expectations. Valuation metrics appear attractive with a P/E of 13.19 and EV/EBITDA of 6.36. Recent news highlights operational excellence and shareholder returns, including $8.5 billion in projected 2026 free cash flow. Technical indicators show support at $132 and resistance at $136.
Outlook remains positive driven by oil price strength and efficient operations, though risks include commodity volatility and capital expenditure pressures. Analyst consensus is strongly bullish with a $156.40 price target, representing 16.6% upside. The absence of sell ratings underscores confidence in EOG's financial health and strategic positioning.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →